analisis pengaruh komorbid dan kejadian efeksamping obat regimen bpAlm terhad…

Background : Indonesia have a high burden of drug-resistant tuberculosis (DR-TB), yet new case finding is still below national estimates. Challenges such as limited facilities, drug unavailability, presence of comorbidities and incidence of adverse drug events may hinder treatment success. In 2022, the World Health Organization (WHO) recommended a BPaLM regimen with shorter treatment durat…